Immunotherapy and targeted drugs could stop some melanomas from returning – Cancer Research UK
|
Immunotherapy and targeted drugs could stop some melanomas from returning
Cancer Research UK In Checkmate 238, patients were also given either nivolumab or another immunotherapy drug called ipilumumab (Yervoy), which has already been trialled for this group of patients but can cause serious side effects that can limit its use. This trial … |
